Understanding the value of cancer drugs-the devil is in the detail

Cancer. 2016 Aug 1;122(15):2292-5. doi: 10.1002/cncr.30044. Epub 2016 May 10.
No abstract available

MeSH terms

  • Antineoplastic Agents / economics*
  • Cancer Care Facilities
  • Cost-Benefit Analysis / methods*
  • Drug Costs*
  • Humans
  • Medical Oncology
  • Models, Economic

Substances

  • Antineoplastic Agents